Rbf Capital, LLC Standard Biotools Inc. Transaction History
Rbf Capital, LLC
- $1.71 Billion
- Q2 2024
A detailed history of Rbf Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Rbf Capital, LLC holds 100,572 shares of LAB stock, worth $193,098. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,572
Previous 441,572
77.22%
Holding current value
$193,098
Previous $1.2 Million
85.12%
% of portfolio
0.01%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding LAB
# of Institutions
148Shares Held
269MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$123 Million9.8% of portfolio
-
Viking Global Investors LP58.7MShares$113 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$41.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$30.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$24.8 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $151M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...